PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
XT vs. IXJ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between XT and IXJ is 0.73, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.7

Performance

XT vs. IXJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Exponential Technologies ETF (XT) and iShares Global Healthcare ETF (IXJ). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%AugustSeptemberOctoberNovemberDecember2025
2.05%
-6.16%
XT
IXJ

Key characteristics

Sharpe Ratio

XT:

0.26

IXJ:

-0.08

Sortino Ratio

XT:

0.47

IXJ:

-0.03

Omega Ratio

XT:

1.06

IXJ:

1.00

Calmar Ratio

XT:

0.25

IXJ:

-0.05

Martin Ratio

XT:

1.11

IXJ:

-0.14

Ulcer Index

XT:

4.04%

IXJ:

5.61%

Daily Std Dev

XT:

17.24%

IXJ:

10.64%

Max Drawdown

XT:

-34.41%

IXJ:

-40.60%

Current Drawdown

XT:

-8.37%

IXJ:

-13.09%

Returns By Period

In the year-to-date period, XT achieves a 1.07% return, which is significantly lower than IXJ's 1.64% return.


XT

YTD

1.07%

1M

-2.75%

6M

0.78%

1Y

5.71%

5Y*

7.21%

10Y*

N/A

IXJ

YTD

1.64%

1M

-0.21%

6M

-8.31%

1Y

0.15%

5Y*

5.73%

10Y*

7.11%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


XT vs. IXJ - Expense Ratio Comparison

XT has a 0.47% expense ratio, which is higher than IXJ's 0.46% expense ratio.


XT
iShares Exponential Technologies ETF
Expense ratio chart for XT: current value at 0.47% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.47%
Expense ratio chart for IXJ: current value at 0.46% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.46%

Risk-Adjusted Performance

XT vs. IXJ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XT
The Risk-Adjusted Performance Rank of XT is 1717
Overall Rank
The Sharpe Ratio Rank of XT is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of XT is 1616
Sortino Ratio Rank
The Omega Ratio Rank of XT is 1515
Omega Ratio Rank
The Calmar Ratio Rank of XT is 2020
Calmar Ratio Rank
The Martin Ratio Rank of XT is 1919
Martin Ratio Rank

IXJ
The Risk-Adjusted Performance Rank of IXJ is 88
Overall Rank
The Sharpe Ratio Rank of IXJ is 99
Sharpe Ratio Rank
The Sortino Ratio Rank of IXJ is 88
Sortino Ratio Rank
The Omega Ratio Rank of IXJ is 88
Omega Ratio Rank
The Calmar Ratio Rank of IXJ is 88
Calmar Ratio Rank
The Martin Ratio Rank of IXJ is 99
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

XT vs. IXJ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Exponential Technologies ETF (XT) and iShares Global Healthcare ETF (IXJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for XT, currently valued at 0.26, compared to the broader market0.002.004.000.26-0.08
The chart of Sortino ratio for XT, currently valued at 0.47, compared to the broader market-2.000.002.004.006.008.0010.0012.000.47-0.03
The chart of Omega ratio for XT, currently valued at 1.06, compared to the broader market0.501.001.502.002.503.001.061.00
The chart of Calmar ratio for XT, currently valued at 0.25, compared to the broader market0.005.0010.0015.000.25-0.05
The chart of Martin ratio for XT, currently valued at 1.11, compared to the broader market0.0020.0040.0060.0080.00100.001.11-0.14
XT
IXJ

The current XT Sharpe Ratio is 0.26, which is higher than the IXJ Sharpe Ratio of -0.08. The chart below compares the historical Sharpe Ratios of XT and IXJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00AugustSeptemberOctoberNovemberDecember2025
0.26
-0.08
XT
IXJ

Dividends

XT vs. IXJ - Dividend Comparison

XT's dividend yield for the trailing twelve months is around 0.65%, less than IXJ's 1.48% yield.


TTM20242023202220212020201920182017201620152014
XT
iShares Exponential Technologies ETF
0.65%0.66%0.41%0.78%0.84%0.77%1.55%1.45%0.97%1.37%1.34%0.00%
IXJ
iShares Global Healthcare ETF
1.48%1.50%1.38%1.17%1.12%1.27%1.42%2.11%1.47%1.73%2.85%1.38%

Drawdowns

XT vs. IXJ - Drawdown Comparison

The maximum XT drawdown since its inception was -34.41%, smaller than the maximum IXJ drawdown of -40.60%. Use the drawdown chart below to compare losses from any high point for XT and IXJ. For additional features, visit the drawdowns tool.


-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-8.37%
-13.09%
XT
IXJ

Volatility

XT vs. IXJ - Volatility Comparison

iShares Exponential Technologies ETF (XT) has a higher volatility of 5.18% compared to iShares Global Healthcare ETF (IXJ) at 3.30%. This indicates that XT's price experiences larger fluctuations and is considered to be riskier than IXJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%AugustSeptemberOctoberNovemberDecember2025
5.18%
3.30%
XT
IXJ
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab